Christer Nordstedt

Directeur/Membre du Conseil chez IRLAB THERAPEUTICS AB

Profil

Christer Nordstedt currently works at Oblique Therapeutics AB, as Chief Executive Officer from 2022, Snevringe AB, as Chairman, IRLAB Therapeutics AB, as Director from 2023, and CINDA PHARMA AB, as Director.
Dr. Nordstedt also formerly worked at Vivesto AB, as Chief Executive Officer in 2022, Wntresearch AB, as Chairman, Orion Diagnostica AB, as Director from 2017 to 2019, Fermion Ltd., as Director from 2017 to 2020, Orion Oyj, as Senior Vice President-Research & Development from 2017 to 2020, Teva GmbH, as Global Research Manager, AstraZeneca AB, as Vice President from 2000 to 2007, Hoffman-LaRoche F & Co. AG, as Senior Vice President, and Eli Lilly Sweden AB, as Senior Vice President from 2011 to 2017.
Dr. Nordstedt received his doctorate degree in 1991 from Karolinska Institutet.

Postes actifs de Christer Nordstedt

Sociétés	Poste	Début
IRLAB THERAPEUTICS AB	Directeur/Membre du Conseil	01/01/2023
Snevringe AB	Président	-
Oblique Therapeutics AB	Directeur Général	01/12/2022
CINDA PHARMA AB	Directeur/Membre du Conseil	-

Anciens postes connus de Christer Nordstedt

Sociétés	Poste	Fin
VIVESTO AB	Directeur Général	30/11/2022
ORION OYJ	Directeur Technique/Scientifique/R&D	05/03/2020
Fermion Ltd.	Directeur/Membre du Conseil	01/01/2020
Orion Diagnostica AB	Directeur/Membre du Conseil	01/01/2019
Eli Lilly Sweden AB	Corporate Officer/Principal	01/02/2017